Evidence map›Paper›PMID 39512969›Full record

ArticleCureus2024

Quality of Life and Complications Among Hemodialysis Patients.

Mohamed Elsherbiny, Sarah Almuhanna, Reem Alathel, Yara Alzahrani, Fahda Alshathri, Abdulrahman Hussamuldin, Alaa Alherz, Sara Abdalla

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mohamed ElsherbinyAnatomy, AlMaarefa University, Riyadh, SAU.
Sarah AlmuhannaNephrology, AlMaarefa University, Riyadh, SAU.
Reem AlathelNephrology, AlMaarefa University, Riyadh, SAU.
Yara AlzahraniNephrology, AlMaarefa University, Riyadh, SAU.
Fahda AlshathriNephrology, AlMaarefa University, Riyadh, SAU.
Abdulrahman HussamuldinNephrology, AlMaarefa University, Riyadh, SAU.
Alaa AlherzNephrology, AlMaarefa University, Riyadh, SAU.
Sara AbdallaNephrology, Alexandria University, Alexandria, EGY.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Patients with renal impairment who require frequent hospitalizations or dialysis must undergo the rigorous process known as hemodialysis (HD). Hemodialysis is a complex treatment for people who require frequent hospital or dialysis appointments, typically three times each week. We aim to explore the quality of life of hemodialysis patients and their complications. Methodology This case-control study focuses on renal failure patients in Riyadh's hemodialysis units. The case group included 50 hemodialysis patients with 50 healthy individuals medically free in the control group who were the same gender and age as the case group. The comparison was made using a quality of life (QoL) short form 36 questionnaire conducted by a trained physician via Google Forms. The data was obtained in February and March 2023. Results The majority of participants were male (68; 68%), aged 40-50 years (42; 42%), 53 (53%) were non-Saudi, 76 (76%) began hemodialysis one year ago, and 30 (30%) developed an infection as a complication. There was a significant statistical relationship between our results and the results of a medical outcome study in the emotional problem and energy/fatigue domains. Conclusion In all domains, HD patients performed worse on subscales than healthy people of the same age and socioeconomic status. The average QoL score for HD patients was lower than that of healthy individuals. There was a statistically significant relationship between healthy people and hemodialysis patients in two domains: emotional problems and energy/fatigue levels.

Indexed as

chronic kidney failurehemodialysiskidney impairmentquality of liferenal failure

Identifiers

PMID39512969
PMCPMC11542671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.